Predictive
Oncology (NASDAQ: POAI) today announced pricing for the public
offering of its common stock that the company announced in a news release on
Tuesday. The company is offering 6,335,537 shares on a “best efforts” basis at
a price of $0.50 each for anticipated gross proceeds of up to $3,167,768.50,
before subtracting placement agent fees, expenses and offering expenses payable
by POAI. Dawson James Securities, Inc. and Paulson Investment Company, LLC are
acting as exclusive placement agents for the offering. Subject to customary closing
conditions, the offering is projected to close on or about October 4, 2019.
In addition, Predictive Oncology announced this morning that
its Skyline Medical division has finalized the sale of ten patented,
FDA-approved STREAMWAY® systems to the leading teaching and research hospital
in upstate New York. Skyline Medical’s STREAMWAY System is a continuous,
direct-to-drain fluid disposal system designed precisely for medical
applications such as radiology, endoscopy, surgery, urology, and cystoscopy
procedures. This sale exceeds the company’s largest single hospital sale to
date and is anticipated to generate 6000 procedures annually.
To view the full press releases, visit http://ibn.fm/qbEVs, http://ibn.fm/NyE5C and http://ibn.fm/NR4Wy
About Predictive Oncology Inc.
Predictive Oncology operates in two business areas: first,
applying artificial intelligence to personalized medicine and drug discovery to
provide personalized medicine solutions for patients and clinicians as well as
clients in the pharmaceutical, diagnostic, and biotech industries, and second,
production of the FDA-approved STREAMWAY® System for automated, direct-to-drain
medical fluid disposal. For more information, visit the company’s website
at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused
on strategic communications. We have executed countless communications programs
to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
